Financings in Brief: Digene
This article was originally published in The Gray Sheet
Executive Summary
Digene: Maker of DNA and RNA tests for disease detection files with SEC for a secondary offering of 2.5 mil. shares, including 2 mil. shares to be offered by the company and 500,000 by a selling shareholder. UBS Securities and Montgomery Securities are underwriters for the offering...